Research Article
C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients
Table 1
Demographic and baseline characteristics of patients with COVID-19.
| | | | All patients (n = 429) | Severe (n = 175) | Nonsevere (n = 254) | value |
| | Age, mean ± SD (range) | | 57.21 ± 16.18 (16–99) | 58.75 ± 15.88 (22–97) | 56.18 ± 16.32 (16–99) | 0.111 |
| | Sex (%) | Male | 241 (56.4) | 106 (60.9) | 135 (53.4) | 0.122 | | Female | 186 (43.6) | 68 (39.1) | 118 (46.6) | |
| | Hospitalization (days) (range) | | 7 (1–37) | 10 (1–37) | 6 (1–31) | <0.001 |
| | Clinical symptoms (%) | Fever | 263 (61.3) | 105 (60) | 158 (62.2) | 0.645 | | Fatigue | 161 (37.5) | 70 (40) | 91 (35.8) | 0.380 | | Headache | 76 (17.7) | 31 (17.7) | 45 (17.7) | 1.000 | | Dry cough | 247 (57.6) | 98 (56) | 149 (58.7) | 0.584 | | Sore throat | 36 (8.4) | 19 (10.9) | 17 (6.7) | 0.126 | | Expectoration | 83 (19.3) | 34 (19.4) | 49 (19.3) | 0.972 | | Hemoptysis | 7 (1.6) | 3 (1.7) | 4 (1.6) | 0.911 | | Chest pain | 61 (14.2) | 22 (12.6) | 39 (15.4) | 0.417 | | Dyspnea | 311 (72.5) | 126 (72) | 69 (72.8) | 0.849 | | Nausea | 81 (18.9) | 37 (21.1) | 44 (17.3) | 0.320 | | Diarrhea | 25 (5.8) | 12 (6.9) | 13 (5.1) | 0.450 | | Constipation | 24 (5.6) | 9 (5.1) | 15 (5.9) | 0.736 | | Anorexia | 118 (27.5) | 53 (30.3) | 65 (25.6) | 0.284 | | Arthralgia | 48 (11.2) | 20 (11.4) | 28 (11) | 0.896 | | Stomach ache | 39 (9.1) | 16 (9.1) | 23 (9.1) | 0.975 | | Dizziness | 54 (12.6) | 21 (12) | 33 (13) | 0.761 | | Loss of smell and taste | 18 (4.2) | 9 (5.1) | 9 (3.5) | 0.417 |
| | Comorbidities (%) | Hypertension | 98 (22.8) | 32 (18.3) | 66 (26) | 0.062 | | Cardiovascular disease | 107 (24.9) | 38 (21.7) | 185 (27.2) | 0.200 | | Diabetes | 119 (27.7) | 49 (28) | 70 (27.6) | 0.920 | | Cancer | 10 (2.3) | 3 (1.7) | 7 (2.8) | 0.482 | | Chronic liver disease | 5 (1.2) | 3 (1.7) | 2 (0.8) | 0.379 | | Chronic kidney disease | 17 (4) | 2 (1.1) | 15 (5.9) | 0.013 | | Brain disease | 9 (2.1) | 6 (3.4) | 3 (1.2) | 0.110 | | COPD | 14 (3.3) | 7 (4) | 7 (2.8) | 0.476 |
| | Complications (%) | Nosocomial pneumonia | 8 (1.9) | 2 (1.1) | 6 (2.4) | 0.359 | | Urinary tract infection | 6 (1.4) | 2 (1.1) | 4 (1.6) | 0.708 | | Shock | 5 (1.2) | 5 (2.8) | 0 (0) | 0.073 | | Acute heart failure | 28 (6.5) | 9 (5.1) | 19 (7.5) | 0.335 | | Arrhythmia | 19 (4.4) | 8 (4.6) | 11 (4.3) | 0.905 | | ARDS | 18 (4.2) | 18 (10.3) | 0 (0) | 0.101 | | Acute kidney failure | 1 (0.4) | 0 (0) | 1 (0.4) | 0.406 |
|
|
Abbreviations: ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease.
|
